MAFG-driven osteosarcoma cell progression is inhibited by a novel miRNA miR-4660

MAFG-driven osteosarcoma cell progression is inhibited by a novel miRNA miR-4660

Osteosarcoma (OS) is the most common primary bone malignancy in the adolescent population. MAFG (v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G) forms a heterodimer with Nrf2 (NF-E2-related factor 2), binding to antioxidant response element (ARE), which is required for Nrf2 signaling...

Full description

Bibliographic Details
Main Authors: Hua-jian Shan, Lun-qing Zhu, Chen Yao, Zhi-qing Zhang, Yuan-yuan Liu, Qin Jiang, Xiao-zhong Zhou, Xiao-dong Wang, Cong Cao
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
osteosarcoma
MAFG
miRNA-4660
Nrf2 signaling
molecularly targeted therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253121000779

Internet

http://www.sciencedirect.com/science/article/pii/S2162253121000779

Similar Items